Choroidal neovascularization
Tóm tắt
Từ khóa
Tài liệu tham khảo
Green, 1996, The uveal tract, 1597
Green, 1985, Pathologic features of senile macular degeneration, Ophthalmology, 92, 615, 10.1016/S0161-6420(85)33993-3
Green, 1991, Clinicopathologic studies of treated choroidal neovascular membranes, Retina, 11, 328, 10.1097/00006982-199111030-00010
Green, 1993, Age-related macular degeneration histopathologic studies, Ophthalmology, 100, 1519, 10.1016/S0161-6420(93)31466-1
Grossniklaus, 1992, Immunohistochemical and histochemical properties of surgically-excised subretinal neovascular membranes in age-related macular degeneration, Am J Ophthalmol, 154, 464, 10.1016/S0002-9394(14)71859-8
Grossniklaus, 1994, Clinicopathologic features of surgically-excised choroidal neovascular membranes, Ophthalmology, 101, 1099, 10.1016/S0161-6420(13)31216-0
Grossniklaus, 1998, Histopathologic and ultrastructural findings of surgically-excised choroidal neovascularization, Arch Ophthalmol, 116, 745, 10.1001/archopht.116.6.745
Grossniklaus, 2000, Correlation of histologic two-dimensional reconstruction and confocal scanning laser microscopic images in eyes with age-related maculopathy, Arch Ophthalmol, 118, 625, 10.1001/archopht.118.5.625
Grossniklaus, 2002, Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization, Mol Vis, 8, 119
Gass, 1994, Biomicroscopic and histopathologic consideration regarding the feasibility of surgical excision of subfoveal neovascular membranes, Am J Ophthalmol, 118, 285, 10.1016/S0002-9394(14)72951-4
Gass, 1997, Stereoscopic atlas of macular diseases, 26
Grossniklaus, 1998, Clinicopathologic correlation of surgically-excised type 1 and type 2 choroidal neovascular membranes, Am J Ophthalmol, 126, 59, 10.1016/S0002-9394(98)00145-7
Lee, 1996, Clinicopathologic features of indocyanine green angiographically-imaged, surgically excised choroidal neovascular membranes, Retina, 16, 64, 10.1097/00006982-199616010-00011
LaFaut, 2000, Clinicopathologic correlation in exudative age-related macular degeneration, Br J Ophthalmol, 84, 239, 10.1136/bjo.84.3.239
Ambati, 2003, Age-related macular degeneration, Surv Ophthalmol, 48, 257, 10.1016/S0039-6257(03)00030-4
Sattler, 1976, Ueber den feineren Bau der Choroidea des Menschen nebst Beiträgen zur pathologischen und vergleichenden Anatomie der Aderhaut, Albert von Graefes Arch Ophthalmol, 22, 1
Oeller JN. Atlas Seltener Ophthalmoskopischer Befunde. Zugleich Evgänzungstateln zu dem Atlas der Ophthalmoskopie. Weisbaden: JF Bergeman, 1900–1905
Junius, 1926, Die scheibenförmige Entargung der Netzhautmitte (Degeneratio maculae luteae disciformis), 132
Holloway, 1928, Disc-like degeneration of the macula with microscopic report concerning a tumor-like mass in the macular region, Trans Am Ophthalmol Soc, 26, 206
Verhoeff, 1937, Pathogenesis of disciform degeneration of the macula, Arch Ophthalmol, 18, 561, 10.1001/archopht.1937.00850100073008
Ashton, 1951, Fundus dystrophy with unusual features, Br J Ophthalmol, 35, 751, 10.1136/bjo.35.12.751
Sorsby, 1949, A fundus dystrophy with unusual features (late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage, and exudates developing into generalized choroidal atrophy with massive pigment proliferation), Br J Ophthalmol, 33, 67, 10.1136/bjo.33.2.67
Gass, 1967, Pathogenesis of disciform detachment of the neuroepithelium. I. General concepts and classification, Am J Ophthalmol, 63, 573
Gass, 1967, Pathogenesis of disciform detachment of the neuroepithelium. III. Senile disciform degeneration, Am J Ophthalmol, 63, 617
Gass, 1967, Pathogenesis of disciform detachment of the neuroepithelium. IV. Fluorescein angiographic studies of senile disciform macular degeneration, Am J Ophthalmol, 63, 645
Sarks, 1973, New vessel formation beneath the retinal pigment epithelium in senile eyes, Br J Ophthalmol, 57, 951, 10.1136/bjo.57.12.951
Green, 1977, Senile macular degeneration, Trans Am Ophthalmol Soc, 75, 180
Lopez, 1991, Pathologic features of surgically-excised subretinal neovascular membranes in age-related macular degeneration, Am J Ophthalmol, 112, 647, 10.1016/S0002-9394(14)77270-8
Saxe, 1993, Ultrastructural features of surgically-excised subretinal neovascular membranes in the ocular histoplasmosis syndrome, Arch Ophthalmol, 111, 88, 10.1001/archopht.1993.01090010092033
Thomas, 1993, Ultrastructural features of surgically-excised idiopathic subfoveal neovascular membranes, Retina, 13, 93, 10.1097/00006982-199313020-00001
Sarks, 1976, Ageing and degeneration in the macular region, Br J Ophthalmol, 60, 324, 10.1136/bjo.60.5.324
Sarks, 1980, Drusen and their relationship to senile macular degeneration, Aust J Ophthalmol, 8, 117, 10.1111/j.1442-9071.1980.tb01670.x
Lopez, 1996, Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes, Invest Ophthalmol Vis Sci, 37, 855
Kvanta, 1996, Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor, Invest Ophthalmol Vis Sci, 37, 1929
Bressler, 1992, Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration, Arch Ophthalmol, 110, 827, 10.1001/archopht.1992.01080180099035
Green, 1971, Senile disciform degeneration of the macula, Arch Ophthalmol, 86, 487, 10.1001/archopht.1971.01000010489001
Olsen, 1996, Subfoveal choroidal neovascularization in punctate inner choroidopathy, Ophthalmol, 103, 2061, 10.1016/S0161-6420(96)30387-4
Elner, 1991, Monocyte dendritic protein gene expression by cytokine-treated human retinal pigment epithelial cells, Lab Invest, 64, 819
Elner, 1996, Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells, Am J Pathol, 136, 745
Dastgheib, 1994, Granulomatous reaction to Bruch's membrane in age-related macular degeneration, Arch Ophthalmol, 112, 813, 10.1001/archopht.1994.01090180111045
Oh, 1999, The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes, Invest Ophthalmol Vis Sci, 40, 1891
Otani, 1999, Expression of angiopoietins and Tie2 in human choroidal neovascular membranes, Invest Ophthalmol Vis Sci, 40, 1912
Hinton, 1999, Signal transduction pathways controlling fibronectin phagocytosis by retinal pigment epithelial cells in vitro, Invest Ophthalmol Vis Sci, 40, S181
Grant, 2002, Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization, Nat Med, 6, 607, 10.1038/nm0602-607
Hattori, 2002, Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone marrow microenvironment, Nat Med, 8, 841, 10.1038/nm740
Espinosa DG, Caicedo A, Hernandez EP, et al. Adult bone marrow derived progenitor cells contribute to choroidal neovascularization and modulate the severity. ARVO Abstracts 2003;3976
Steen, 1998, Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes, Invest Ophthalmol Vis Sci, 39, 2194
Amin, 1994, Growth factor localization in choroidal neovascularization, Invest Ophthalmol Vis Sci, 35, 3178
Reddy, 1995, Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome, Am J Ophthalmol, 120, 291, 10.1016/S0002-9394(14)72158-0
Ogata, 1997, Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization, Curr Eye Res, 16, 9, 10.1076/ceyr.16.1.9.5121
Hangai, 2001, Angiopoietin-1 upregulation by vascular endothelial growth factors in human retinal pigment epithelial cells, Invest Ophthalmol Vis Sci, 42, 1617
Schwartz SD, Tran D, Hsu YSJ, et al. Gene transfer of pigment epithelium-derived factor (PEDF) blocks laser-induced choroidal neovascularization (CNV) in male cynomolgus monkies. ARVO Abstracts 2002;3915
Yamashita, 2000, Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors, Nature, 408, 92, 10.1038/35040568
Luttun, 2000, The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke, Curr Atheroscler Res, 2, 407, 10.1007/s11883-000-0079-z
Penfold, 1984, An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane, Aust J Ophthalmol, 12, 23, 10.1111/j.1442-9071.1984.tb01120.x
Penfold, 1985, Senile macular degeneration, Graefes Arch Clin Exp Ophthalmol, 223, 69, 10.1007/BF02150948
Gass, 1973, Choroidal neovascular membranes—their visualization and treatment, Trans Am Acad Ophthalmol Otolaryng, 77, 310
Gass, 1972, Drusen and disciform macular detachment and degeneration, Trans Am Ophthalmol Soc, 70, 409
Watzke, 1968, Light coagulation for hemorrhagic disciform degeneration of the macula, Trans Am Acad Ophthalmol Otolaryngol, 72, 389
Jepson, 1969, Photocoagulation of disciform macular degeneration, Am J Ophthalmol, 67, 920, 10.1016/0002-9394(69)90087-7
L'Esperance, 1971, Argon and ruby laser photocoagulation of disciform macular disease, Trans Am Acad Otolaryngol, 75, 609
Schatz, 1973, Exudative senile maculopathy. II. Complications of argon laser treatment, Arch Ophthalmol, 90, 197, 10.1001/archopht.1973.01000050199004
Bird, 1974, Recent advances in the treatment of senile macular degeneration by photocoagulation, Br J Ophthalmol, 58, 367, 10.1136/bjo.58.4.367
1982, Argon laser photocoagulation for senile macular degeneration, Arch Ophthalmol, 100, 912, 10.1001/archopht.1982.01030030920003
1990, Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration, Arch Ophthalmol, 108, 825, 10.1001/archopht.1990.01070080067037
1993, Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration, Arch Ophthalmol, 111, 1200, 10.1001/archopht.1993.01090090052019
1983, Argon laser photocoagulation for ocular histoplasmosis, Arch Ophthalmol, 101, 1347, 10.1001/archopht.1983.01040020349002
1989, Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions after ocular histoplasmosis, Arch Ophthalmol, 107, 344, 10.1001/archopht.1989.01070010354023
1983, Argon laser photocoagulation for idiopathic neovascularization, Arch Ophthalmol, 101, 1358, 10.1001/archopht.1983.01040020360003
1999, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin, Arch Ophthalmol, 117, 1329, 10.1001/archopht.117.10.1329
2001, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin—two year results of 2 randomized clinical trials. Tap Report 2, Arch Ophthalmol, 119, 198
2001, Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin, Ophthalmology, 108, 841, 10.1016/S0161-6420(01)00544-9
De Juan, 1988, Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration, Am J Ophthalmol, 105, 25, 10.1016/0002-9394(88)90116-X
Thomas, 1991, Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome, Am J Ophthalmol, 111, 1, 10.1016/S0002-9394(14)76888-6
Lambert, 1992, Surgical excision of subfoveal neovascular membranes in age-related macular degeneration, Am J Ophthalmol, 113, 257, 10.1016/S0002-9394(14)71576-4
Hsu, 1995, Clinicopathologic studies of an eye after submacular membranectomy for choroidal neovascularization, Retina, 15, 43, 10.1097/00006982-199515010-00009
Rosa, 1996, Clinicopathologic correlation of submacular membranectomy with retention of good vision in a patient with age-related macular degeneration, Arch Ophthalmol, 114, 480, 10.1001/archopht.1996.01100130476025
2000, Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes. Submacular Surgery Trials report number 1, Am J Ophthalmol, 130, 387
De Juan, 1998, Translocation of the retina for the management of subfoveal choroidal neovascularization II, Am J Ophthalmol, 25, 635, 10.1016/S0002-9394(98)00018-X
Toth, 2001, Macular translocation with 360-degree peripheral retinectomy, Retina, 21, 293, 10.1097/00006982-200108000-00001
Grossniklaus, 2002, Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization, Retina, 22, 818, 10.1097/00006982-200212000-00027
Marcus DM, Maguire MG, Maguire AM, Fine SL. The age-related macular degeneration radiotherapy trial: Baseline characteristics. ARVO Abstracts 2002;1207
Ciulla, 2001, Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model, Arch Ophthalmol, 119, 399, 10.1001/archopht.119.3.399
Ranson, 2002, Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularization after laser treatment in macular degeneration, Br J Ophthalmol, 86, 527, 10.1136/bjo.86.5.527
Penfold, 2000, Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line, Clin Exp Immunol, 121, 458, 10.1046/j.1365-2249.2000.01316.x
Penn, 2001, The effect of an angiogenic steroid on neovascularization in a rat model of retinopathy of prematurity, Invest Ophthalmol Vis Sci, 42, 283
D'Amico, 2003, Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD), Retina, 23, 14, 10.1097/00006982-200302000-00003
Krzystolik, 2002, Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment, Arch Ophthalmol, 120, 338, 10.1001/archopht.120.3.338
Singerman LJ, for the EyeTech Study Group. Anti-VEGF therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: Phase 1B results. ARVO Abstracts 2002;2908
2002, Preclinical and phase 1a clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for treatment of exudative age-related macular degeneration, Retina, 22, 143, 10.1097/00006982-200204000-00002
Gehlbach, 2003, Periocular injection of an adenoviral vector encoding pigment-epithelium derived factor inhibits choroidal neovascularization, Gene Ther, 10, 637, 10.1038/sj.gt.3301931
Rasmussen, 2001, Clinical protocol. An open-label, phase 1, single administration dose-escalation study of ADGVPEDF. 11D (ADPEDF) in neovascular age-related macular degeneration (AMD), Hum Gene Ther, 12, 2029